KRYS Krystal Biotech, Inc.
KRYS Krystal Biotech, Inc.
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-23 1 neutral converging
POC $328.51 · VWAP $292.82 · +6.4% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CEO, President sold $18M, Sep 4
Coverage
1 watchlist
KRYS Price Structure
Loading timeframes…
Peers
Every watchlist KRYS belongs to, members best 30-day change first — KRYS highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How KRYS's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about KRYS from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 1 day ago · Oct 22
- KRYS News Today | Why did Krystal Biotech stock go down today? $KRYS
- Krystal Biotech, Inc. Common Stock (KRYS) Stock Price & Analysis | Bamboo
- Krystal Biotech (KRYS) — Stock After Hours
- Short Interest
- Krystal Biotech (KRYS) Q2 2026 Earnings Call Transcript | The Motley Fool
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
KRYS research tape
55 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.